Zhang et al. also reported that autoantibodies against a panel of four TAAs (i.e., c-Myc, HCCR, p53, and p62) provided a high diagnostic efficiency for early-stage ESCC detection [33]. This evidence concerns the gene LETMD1 and esophageal squamous cell carcinoma.